Vanguard Capital Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,925
Closed -$278K 145
2025
Q3
$278K Buy
+10,925
New +$270K 0.22% 95
2025
Q1
Sell
-9,050
Closed -$240K 128
2024
Q4
$240K Sell
9,050
-1,950
-18% -$52.9K 0.26% 81
2024
Q3
$318K Sell
11,000
-2,034
-16% -$59.3K 0.33% 66
2024
Q2
$365K Buy
13,034
+2,817
+28% +$77.6K 0.25% 85
2024
Q1
$284K Buy
10,217
+412
+4% +$11.4K 0.2% 97
2023
Q4
$282K Sell
9,805
-1,711
-15% -$51.7K 0.23% 95
2023
Q3
$382K Buy
11,516
+1,331
+13% +$47.1K 0.35% 65
2023
Q2
$374K Buy
10,185
+360
+4% +$14K 0.34% 68
2023
Q1
$401K Sell
9,825
-89
-0.9% -$3.84K 0.4% 60
2022
Q4
$508K Buy
9,914
+108
+1% +$5.18K 0.59% 48
2022
Q3
$429K Sell
9,806
-13,065
-57% -$635K 0.52% 53
2022
Q2
$1.2M Sell
22,871
-9,513
-29% -$485K 1.35% 15
2022
Q1
$1.68M Sell
32,384
-6,922
-18% -$359K 1.2% 16
2021
Q4
$2.32M Sell
39,306
-25,751
-40% -$1.28M 1.67% 10
2021
Q3
$2.8K Buy
65,057
+30,540
+88% +$1.35M 1.88% 10
2021
Q2
$1.35M Buy
34,517
+2,327
+7% +$90.5K 1.03% 21
2021
Q1
$1.16M Buy
32,190
+19,440
+152% +$690K 0.98% 26
2020
Q4
$468K Buy
+12,750
New +$468K 0.43% 62

Other funds holding PFE

Vanguard Capital Wealth Advisors's PFE Position: Q4 2025 in Review

Vanguard Capital Wealth Advisors sold out of Pfizer (PFE) in Q4 2025, closing a stake of 10,925 shares — an estimated $278K sold.

Vanguard Capital Wealth Advisors first reported a position in PFE in Q4 2020 and held it in 18 quarters. The position peaked at $2.32M in Q4 2021. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Vanguard Capital Wealth Advisors reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Vanguard Capital Wealth Advisors sold 10,925 Pfizer shares in Q4 2025, an estimated $278K.
  • Vanguard Capital Wealth Advisors first reported a position in Pfizer in Q4 2020 and held it in 18 quarters.
  • Vanguard Capital Wealth Advisors's Pfizer position peaked at $2.32M in Q4 2021.
  • 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Vanguard Capital Wealth Advisors's 13F filing for Q4 2025, filed 16 Jan 2026.